MiNK Therapeutics INKT
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 11.15 | 103.25 | -0.54 | -3,277 | -3 | |
| 2025Q3 | 14.00 | 110.25 | -0.63 | -3,184 | -3 | |
| 2025Q2 | 7.39 | 95.63 | -1.06 | -4,052 | -4 | |
| 2025Q1 | 8.64 | 97.61 | -0.70 | -2,701 | -3 | |
| 2024Q4 | 6.97 | 101.62 | -0.62 | -2,503 | -2 | |
| 2024Q3 | 7.50 | 104.32 | -0.42 | -1,885 | -2 | |
| 2024Q2 | 9.49 | 113.66 | -0.72 | -3,071 | -3 | |
| 2024Q1 | 9.08 | 100.45 | -1.10 | -3,830 | -4 | |
| 2023Q4 | 10.70 | 100.77 | -1.54 | -5,500 | -5 | |
| 2023Q3 | 11.00 | 102.09 | -1.50 | -5,224 | -5 | |
| 2023Q2 | 21.00 | 102.36 | -1.80 | -6,343 | -6 | |
| 2023Q1 | 18.95 | -1.70 | -5,854 | -6 | ||
| 2022Q4 | 26.10 | 98.33 | -2.30 | -7,889 | -8 | |
| 2022Q3 | 21.10 | 123.83 | -1.90 | -7,987 | -6 | |
| 2022Q2 | 14.10 | 125.40 | -1.80 | -7,698 | -6 | |
| 2022Q1 | 22.50 | 94.83 | -2.30 | -7,374 | -8 | |
| 2021Q4 | 44.60 | 110.39 | -1.50 | -6,362 | -6 | |
| 2021Q3 | 99.93 | -5.90 | -13,376 | -14 | ||
| 2021Q2 | -2.23 | -4,453 | -6 | |||
| 2021Q1 | -1.36 | -3,693 | -4 |